Welcome to the 2nd ADC Process Development Summit!
With cutting-edge strategies and industry insights, the 2nd ADC Process Development Summit returned with a mission to boost conjugation yield, optimize purification, and streamline production to meet regulatory standards all whilst minimizing costs and timelines.
The 2024 summit bought experts from AstraZeneca, Bristol Myers Squibb, Pfizer and a community of industry professionals in process development, conjugation, purification, control, CMC, and engineering. With a focused discussion on process development challenges, innovative solutions and practical takeaways, leave equipped with the technical knowledge and connections to revolutionize your antibody-drug conjugate manufacturing process.
This Summit was a must attend for everyone looking to increase conjugation yield and enhance TFF, implement rigorous control strategies for superior drug substance quality, develop scalable processes to cut unit operations, accelerate production timelines, and navigate regulatory landscapes with ease.
This Summit was designed to be a place where innovation meets implementation, ensuring your ADC process development reached its optimal efficacy and efficiency!
The 2024 World-Class Speaker Faculty Included:
Previously Attending Companies Include:
Proud to be Part of the World ADC Series:
Designed to make sure ADC experts are up to date with industry's advancements, the World ADC Event Series unites 1,500+ experts in the field to provide valuable insights and connections to advance ADCs as a first-option treatment. From globally leading conferences to webinars and industry reports, whatever the information you need, the 2nd ADC Process Development Summit can offer you the insights you need to optimize your purification & conjugation processes, to reduce unit operations whilst retaining drug substance quality to stay ahead of the growing field.
